Clinical Therapeutics · 2016 · 25 citations · 38 references
PharmacyOncologyPharmacoeconomicsCost-effectiveness AnalysisCost-utility AnalysisPharmacoeconomic ModelingCost-effectiveness ModelingHealthcare Cost AnalysisMarkov ModelingModel-based Economic EvaluationOutcome ValuationPharmacoeconomic EvaluationChronic Lymphocytic Leukemia TherapyClinical Value AssessmentCost-effectivenessCost-effectiveness Acceptability FrontierFludarabine-based RegimensQaly GainsRefractory Chronic Lymphocytic LeukemiaSurvival Distributions
38
Michael Hallek, Bruce D. Cheson, Daniel Catovsky et al. · Blood · 2008 · 3.2K citations · Full text
Medicine, Hematology, Oncology +14
Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
Valentin Goede, Kirsten Fischer, Raymonde Busch et al. · New England Journal of Medicine · 2014 · 1.5K citations · Full text